πŸ‘¨β€βš•οΈ Chapter 152: Transitioning to Adult Care & Chapter 484.3: Supraventricular Tachycardia
Nelson's Textbook of Pediatrics 22e | ACHD Transition Β· SVT Β· Acute management Β· Long-term care Β· MCQ bank Β· Clinical approach
πŸ“Œ Transition to Adult Care – Key elementsβœ” Start planning by age 14-16 | βœ” Portable medical summary (diagnosis, surgeries, medications, allergies) | βœ” Identify adult congenital heart disease (ACHD) specialist | βœ” Discuss contraception, pregnancy risks, insurance, lifestyle | βœ” Screen for depression, anxiety, adherence | βœ” Use HEADSS assessment for adolescents.
πŸ“Œ ACHD – High-risk conditionsβœ” Fontan circulation | βœ” Systemic right ventricle (TGA after atrial switch) | βœ” Pulmonary arterial hypertension (Eisenmenger) | βœ” Severe aortic stenosis/coarctation with aneurysm | βœ” Mechanical valve on anticoagulation | βœ” Cyanotic CHD with residual defects.
πŸ“Œ Supraventricular Tachycardia (SVT) – Mechanismsβœ” AVRT (accessory pathway – Wolff-Parkinson-White) – most common in infants | βœ” AVNRT (dual AV node physiology) – common in adolescents | βœ” Atrial flutter (intra-atrial reentry) – post-op CHD | βœ” Atrial ectopic tachycardia (automatic) – often incessant.
πŸ“Œ SVT – ECG featuresβœ” Narrow QRS (<0.09 sec) regular tachycardia | βœ” Rate: newborns >220 bpm, children >180 bpm | βœ” P waves: retrograde (inverted in II, III, aVF) or absent | βœ” Sudden onset/termination | βœ” WPW: delta wave, short PR in sinus rhythm.
πŸ“Œ Acute SVT management – ABCDEβœ” Vagal maneuvers (ice to face in infants, Valsalva in older) | βœ” Adenosine 0.1 mg/kg rapid IV push (max 6 mg) β†’ repeat 0.2 mg/kg (max 12 mg) | βœ” Synchronized cardioversion if unstable (0.5-1 J/kg) | βœ” Esophageal overdrive pacing if available.
πŸ“Œ Long-term SVT treatmentβœ” Beta-blockers (propranolol, nadolol) first-line | βœ” Digoxin (avoid in WPW) | βœ” Flecainide, propafenone, sotalol or amiodarone for refractory | βœ” Catheter ablation (curative) – especially AVRT, AVNRT, atrial flutter | βœ” Infant SVT often resolves by 12-18 months.
πŸ“Œ WPW – risk stratificationβœ” Syncope + WPW = high risk | βœ” Intermittent preexcitation does not exclude risk | βœ” Invasive EP study for high-risk athletes/symptomatic | βœ” Ablation for high-risk accessory pathways (short refractory period).
πŸ“Œ Transition: Transfer of Care Checklistβœ” Transfer summary by age 18 | βœ” Adult provider introduction | βœ” Establish self-management skills (medication, appointments, insurance) | βœ” Discuss reproductive health (contraindicated pregnancy conditions: PAH, severe ventricular dysfunction, Fontan complications).
πŸ” Step 1: Recognize presentation
Infant: poor feeding, irritability, pallor, tachypnea β†’ heart failure if prolonged. Child/adolescent: palpitations, chest discomfort, dizziness, syncope, β€œsudden fast heart rate”.
πŸ“ˆ Step 2: Initial evaluation
Vitals (HR, BP, oxygen saturation), pulse oximetry, 12-lead ECG (wide vs narrow QRS, rate, P wave morphology). Bedside monitoring.
🩺 Step 3: Distinguish SVT from sinus tachycardia
SVT: fixed HR >220 (infant), >180 (child); abrupt onset; no variability; P wave abnormal axis. Sinus tachycardia: gradual, rate varies, P wave normal axis, resolves with sedation/treating cause.
πŸ”„ Step 4: Determine mechanism (ECG clues)
AVRT (WPW): short PR + delta wave in sinus rhythm. AVNRT: no preexcitation, P waves buried in QRS. Atrial flutter: sawtooth flutter waves. JET: AV dissociation.
🚨 Step 5: Assess stability
Unstable (poor perfusion, hypotension, altered consciousness) β†’ immediate synchronized cardioversion (0.5-1 J/kg). Stable β†’ vagal maneuvers/adenosine.
1️⃣ Immediate (unstable patient)
β–ͺ Synchronized cardioversion: 0.5-1 J/kg, repeat 2 J/kg.
β–ͺ If IV access: adenosine while preparing cardioversion.
β–ͺ Prepare for intubation/resuscitation if deteriorated.
2️⃣ Stable patient – Vagal maneuvers
β–ͺ Infant: ice bag to face (covering eyes and nose) for 15-30 sec.
β–ͺ Child/adolescent: Valsalva (blow through syringe, strain), modified Valsalva (supine to leg raise), carotid massage (avoid in children).
β–ͺ No ocular pressure.
3️⃣ Pharmacologic (stable)
β–ͺ Adenosine: 0.1 mg/kg rapid IV push (max 6 mg) followed by saline flush; if no effect β†’ 0.2 mg/kg (max 12 mg).
β–ͺ Second-line: esmolol (IV), procainamide, amiodarone (only if refractory).
4️⃣ Post-conversion management
β–ͺ ECG documentation, echocardiogram to exclude structural disease.
β–ͺ Start oral propranolol (1-2 mg/kg/day) or nadolol.
β–ͺ Avoid digoxin/verapamil if WPW (risk of VF).
β–ͺ Refer to pediatric cardiology for long-term plan (ablation vs medication).
5️⃣ Long-term & Transition (CHD patients)
β–ͺ For ACHD with residual arrhythmia: ablation, risk of recurrence.
β–ͺ Transition planning: transfer of care summary, adult EP consult.
β–ͺ Pregnancy counseling for women with SVT/WPW.
❓ Reflex prompt 1: A 2-week-old with heart rate 280 bpm, pale, poor feeding. What is your immediate action?
βœ… Answer: Unstable β†’ synchronized cardioversion 0.5-1 J/kg. If IV in place, adenosine first while preparing cardioverter.
❓ Reflex prompt 2: A 12-year-old with recurrent palpitations, ECG shows delta wave and short PR. Which medications are contraindicated?
βœ… Answer: Digoxin and verapamil (calcium channel blockers) – can accelerate antegrade conduction over accessory pathway β†’ VF risk. Use beta-blockers or refer for ablation.
❓ Reflex prompt 3: A 16-year-old with repaired tetralogy of Fallot presents with irregular tachycardia, ECG shows sawtooth flutter. Most likely arrhythmia?
βœ… Answer: Atrial flutter (intra-atrial reentry). Common after atrial surgery. Needs anticoagulation before cardioversion (if >48hr) and may respond to class III agents or ablation.
❓ Reflex prompt 4: What are the essential components of a transition readiness plan for a 17-year-old with Fontan circulation?
βœ… Answer: Portable medical summary, cardiac diagnosis & surgeries, list of medications, allergy, identify adult CHD specialist, discuss contraception (avoid OCPs), pregnancy risk (high risk), psychosocial assessment, insurance transfer, and self-management skills.
❓ Reflex prompt 5: Infant SVT: what is the success rate of adenosine? When would you use esophageal pacing?
βœ… Answer: Adenosine success >90%. Esophageal pacing used when adenosine contraindicated (asthma, severe bronchospasm) or to differentiate from atrial flutter.
πŸ“Œ Chapter 152 – Transitioning to Adult Care (Nelson 22e)
β€’ Goal: Prepare youth with chronic conditions (CHD, cardiomyopathy) for adult healthcare. Start by age 14-16.
β€’ Key elements: Portable medical summary (diagnosis, surgeries, medications, allergies, last echo), transition readiness assessment, transfer of care to ACHD specialist.
β€’ High-risk conditions for pregnancy: Pulmonary hypertension, Fontan with complications, systemic RV dysfunction, severe aortic stenosis, Marfan with aorta >45mm. Contraindicated pregnancy.
β€’ Psychosocial: Screen for depression, anxiety, adherence, substance use (HEADSS). Promote self-advocacy.

πŸ“Œ Chapter 484.3 – Supraventricular Tachycardia (SVT)
β€’ Mechanisms: AVRT (WPW – accessory pathway) most common in infants; AVNRT (dual AV node) adolescents; atrial flutter post-surgery CHD.
β€’ Diagnosis: Narrow QRS tachycardia, rate >220 (infants) / >180 (children), sudden onset/offset. Differentiate from sinus tachycardia (gradual, variable).
β€’ Acute treatment: Unstable β†’ synchronized cardioversion (0.5-1 J/kg). Stable β†’ vagal maneuvers (ice to face, Valsalva), adenosine 0.1-0.2 mg/kg IV push.
β€’ Chronic management: Beta-blockers first-line (propranolol, nadolol). Avoid digoxin/verapamil in WPW. Catheter ablation curative (especially AVRT/AVNRT).
β€’ WPW risk: Syncope, rapid conduction during atrial fibrillation, family history sudden death β†’ EP study and ablation.
β€’ Transition relevance: Patients with CHD and SVT need lifelong EP follow-up, pregnancy risk assessment, and planning for ablation in specialized ACHD centers.

πŸ’‘ Clinical Pearl: In infants, SVT often presents with heart failure after 24h; suspect if unexplained poor feeding/irritability. Adenosine is safe and first-line in stable infants.